A young patient in his twenties was brought to the hospital’s emergency department due to on and off fever for 5 days associated with body pains only and then was tested for Covid19 which turned out to be positive then was immediately referred to other health care facility that can manage patients with CoviD19 disease adequately…then a few days after the young patient died due to a lung complication( ARDS-Acute Respiratory Distress Syndrome) from CoviD19 disease. In another health care facility setting, here came two women at the emergency department, one was in her late forties with hypertension and diabetes and the other was also hypertensive and diabetic at 58 years old, both of them had fever, cough and poor appetite for three days without difficulty of breathing and was also tested for CoviD19 disease which both results turned out to be positive and was subsequently admitted. Then 4 to 5 days after, both of them develop shortness of breath and was transferred to the intensive care unit for proper and guarded management. Then a few days after,the woman on her late forties died due to heart problem complication and then the other woman on her late fifties survived after 18 days in her hospital stay and was subsequently discharge well.
CoviD19 infects 8.46 million and kills more than 453,000 thousand victims:
Since December 2019 when the first case of Covid19 disease was reported from Wuhan China...and then spreads all over the world and kills hundreds of thousands and destroys global economy. Thus many scientists from influential countries around the globe partnered and collaborated with the wealthy multinational pharmaceutical industries to develop a drug/s and vaccine/s for the novel coronavirus or SARS CoV-2 that causes the dreaded CoviD19 disease. This collaboration studies or the Solidarity Clinical Trial is headed by no other than the the World Health Organization ( WHO ). The purpose and aims of the Solidarity Clinical Trial is to rapidly discover a definite drug/s for the treatment of CoviD19 disease as a current evolving situation globally. Many drugs that was repurposed under the WHO compassionate use for Covid19 disease was used while awaiting strict peer reviewed clinical study result protocol. And because there is no effective or definite drug treatment available for the new coronavirus infection, morbidity and mortality rates continue to piled up.
Recently release Promising Repurposed Drugs for CoviD19 patients:Solidarity Clinical Trials by WHO
The world is very thankful enough that a cheap drug such as dexamethasone ( intravenous or oral form ,intravenous remdesivir by Gilead and convalescent plasma was repurposed ( US-FDA EUA ) and in combination with other medications (ACTT2 ) showed promising results by shortening hospital patients stay in the severely infected hospitalised patients and thus save lives. And the strict implementations of quarantines and lockdowns in each locality with the application of good personal hygiene and health practices contributed to ” Flatten the curve ” against CoviD19 disease worldwide.
Dr. Laertes B. Amihan talked with quarantine guards.
While waiting for the development of a new definite drug treatment for the dreaded Covid19 disease, infected patients still continue to rise in some areas and others are still in watchful waiting for the second novel coronavirus outbreak will occur, since most of the government loosens their grip with regards to the strict implementation of the enhanced community quarantines ( ECQ ) or lockdowns and changed it to a more relaxed modified generalized community quarantines or MGCQ. Thus some people unknowingly tend to forgot the protocols and as “social animals” mingles freely closely with each other with a big possibility of spreading the virus then a possible second wave CoviD19 outbreak will happen in the near future.
If the possibility of second CoviD19 outbreak is highly entertained…then more sick patients will be going to our health care facilities presenting initially with mild symptoms ( 81% of patients ), severe ( 14% ) and critical ( 5% ). Based from foreign literature that there are subsets of the patients presenting with mild symptoms of Covid19 disease deteriorates or progress to critical illness regardless of having a comorbid factor or not having a one. Although we as clinicians already had the knowledge of who are the possible candidate that will deteriorate base from their history and comorbidity but still it will be really hard for us to pinpoint who are the patients will deteriorate and progress to critical illness. A new study will give a solution to that…and that is by using Artificial Intelligence or AI in health care.